Veverimer for bone loss in adults with osteopenia
Part of Bones, joints & muscles, Hormones & metabolism clinical trials.
This study tests whether a medication called veverimer can help reduce bone loss in adults with osteopenia (early bone thinning) by lowering the acid load from their diet. Participants must be 50 or older, eat a typical Western diet, and have low bone density but not full osteoporosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years old or older.
- Women must have gone through menopause and had no periods for at least 5 years.
- You have osteopenia (low bone density, but not full osteoporosis).
- You typically eat a diet that is high in acid-producing foods (like meat, cheese, and grains).
- You do not have a respiratory illness, COPD, asthma, or other serious health conditions listed in the exclusion criteria.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether combining resistance training with the drug rapamycin can improve bone formation in postmenopausal women who have lower-than-normal bone density but not osteoporosis. It aims to find a new way to strengthen bones and prevent fractures.
This trial tests whether specific meals can lower bone breakdown in postmenopausal women with osteopenia (thinning bones). It may help prevent osteoporosis by identifying a meal plan that protects bone health.
This study tests whether a daily probiotic supplement can help prevent bone loss in adults aged 60 and older. It is designed for people who have chosen not to take standard osteoporosis medications.
This study tests whether a bone-building medication (romosozumab) combined with estrogen replacement therapy can improve bone density in young women with hypothalamic amenorrhea (missing periods due to low energy or stress). It aims to find a better treatment for low bone density caused by this condition.
This study compares two treatment plans for women with osteoporosis to see which one improves hip bone density more. Participants will either get two medications in sequence (romosozumab followed by denosumab) or one medication (zoledronic acid), both given as injections or infusions. The goal is to find a treatment that reduces fracture risk.
This trial studies whether doing a structured bone-focused exercise program, taking alendronate (a medication that slows bone loss), and making a calorie-reducing diet can improve bone strength in people with low bone density. It also compares different combinations to see what helps most and is safest for you.
Hear when a new Osteopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.